跳转至内容
Merck
CN

139858

Sigma-Aldrich

6-甲氧基吲哚

98%

别名:

NSC 92517

登录查看公司和协议定价

关于此项目

经验公式(希尔记法):
C9H9NO
CAS Number:
分子量:
147.17
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

98%

mp

90-92 °C (lit.)

SMILES字符串

COc1ccc2cc[nH]c2c1

InChI

1S/C9H9NO/c1-11-8-3-2-7-4-5-10-9(7)6-8/h2-6,10H,1H3

InChI key

QJRWYBIKLXNYLF-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

6-甲氧基吲哚可用于在酸中研究血清素和其他相关化合物质子激发态形式的荧光。它用于制备:
  • 色氨酸双加氧酶抑制剂吡啶基-乙烯基-吲哚,潜在的抗癌免疫调节剂
  • 吲哚基吲唑和吲哚基吡唑吡啶,白介素-2诱导型T细胞激酶抑制剂
  • 二吲哚基氧基吲哚,抗癌剂
  • 苯甲酰基哌嗪基吲哚基乙烷二酮衍生物,HIV-1抑制剂
  • 3-芳酰基吲哚,抗癌剂
  • 吲哚基和异喹啉基的邻氨苯甲酸,PPARδ部分激动剂
  • 杂芳基酮,VEGFR-2抑制剂
  • 作为反应物,用于制备色氨酸双加氧酶抑制剂吡啶基-乙烯基-吲哚——一种潜在的抗癌免疫调节剂
  • 作为反应物,用于合成吲哚基吲唑和吲哚基吡唑吡啶,作为白介素-2诱导型T细胞激酶抑制剂
  • 作为反应物制备抗癌剂二吲哚基氧基吲哚
  • 作为反应物制备苯甲酰基哌嗪基吲哚基乙烷二酮衍生物,作为HIV-1抑制剂
  • 作为反应物制备抗癌剂3-芳酰基吲哚
  • 作为反应物制备吲哚基和异喹啉基的邻氨苯甲酸,作为PPARδ部分激动剂
  • 作为反应物制备杂芳基酮,作为VEGFR-2抑制剂

生化/生理作用

6-甲氧基吲哚抑制髓过氧化物酶的氯化活性,并抑制活化白细胞的次氯酸产生

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

V F Ximenes et al.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 38(11), 1575-1583 (2005-11-01)
Hypochlorous acid (HOCl) released by activated leukocytes has been implicated in the tissue damage that characterizes chronic inflammatory diseases. In this investigation, 14 indole derivatives, including metabolites such as melatonin, tryptophan and indole-3-acetic acid, were screened for their ability to
Ahmed Kamal et al.
Bioorganic & medicinal chemistry letters, 20(17), 5229-5231 (2010-08-03)
A simple and highly efficient method has been developed for the synthesis of 3,3-diindolyl oxyindoles by the reaction of indoles with isatin or 5-fluoro isatin using a catalytic amount (5 mol%) of FeCl(3) at room temperature in a short reaction
Eugene L Piatnitski Chekler et al.
Bioorganic & medicinal chemistry letters, 18(15), 4344-4347 (2008-07-22)
We have discovered novel inhibitors of VEGFR-2 kinase with low nanomolar potency in both enzymatic and cell-based assays. Active series are heteroaryl-ketone compounds containing a central aromatic ring with either an indazolyl or indolyl keto group in the ortho orientation
Matthias Herdemann et al.
Bioorganic & medicinal chemistry letters, 20(23), 6998-7003 (2010-10-23)
A series of novel compound libraries inhibiting interleukin-2 inducible T cell kinase (ITK) were designed, synthesized and evaluated. In the first design cycle two library scaffolds were identified showing low micromolar inhibition of ITK. Further iterative design cycles including crystal
Fluorescence of protonated excited-state forms of 5-hydroxytryptamine (serotonin) and related indoles.
R F Chen
Proceedings of the National Academy of Sciences of the United States of America, 60(2), 598-605 (1968-06-01)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持